开源证券给予爱美客买入评级，公司信息更新报告：2025H1业绩承压，持续研发期待业绩修复

Group 1 - The core viewpoint of the report is that Aimeike (300896.SZ) is given a "buy" rating despite a 29.6% year-on-year decline in net profit attributable to shareholders in the first half of 2025, indicating some pressure on performance [2] - The company's core product categories are experiencing performance pressure, leading to a decline in profitability [2] - Aimeike is pursuing a second growth curve through the acquisition of REGEN and is focusing on continuous research and development to drive performance recovery [2]